358 results on '"Fernandez-Nebro A"'
Search Results
2. IMID-Biobank: Biobank of immune-mediated inflammatory diseases (IMIDs)
3. Multidisciplinary consensus on the use of hydroxychloroquine in patients with systemic lupus erythematosus
4. Impact of the COVID-19 pandemic on psychosocial health in rheumatic patients: A longitudinal study
5. Personalized cardiovascular risk assessment in Rheumatoid Arthritis patients using circulating molecular profiles and their modulation by TNFi, IL6Ri, and JAKinibs
6. Use of risk chart algorithms for the identification of psoriatic arthritis patients at high risk for cardiovascular disease: findings derived from the project CARMA cohort after a 7.5-year follow-up period
7. Adiposity is associated with expansion of the genus Dialister in rheumatoid arthritis patients
8. Analysis of comorbidity in rheumatoid arthritis–associated interstitial lung disease: a nested case-cohort study
9. Effectiveness and safety of tocilizumab in monotherapy in biologic-naïve and non-naïve patients with rheumatoid arthritis in a real-world setting
10. Relationship between polyautoimmunity and sarcopenic obesity in rheumatoid arthritis patients
11. Relación entre poliautoinmunidad y obesidad sarcopénica en pacientes con artritis reumatoide
12. Collinsella is associated with cumulative inflammatory burden in an established rheumatoid arthritis cohort
13. Hospitalization and mortality from COVID-19 of patients with rheumatic inflammatory diseases in Andalusia
14. Hospitalizaciones y mortalidad por COVID-19 en pacientes con enfermedades inflamatorias reumáticas en Andalucía
15. Longitudinal analysis of blood DNA methylation identifies mechanisms of response to tumor necrosis factor inhibitor therapy in rheumatoid arthritis
16. Antimalarials exert a cardioprotective effect in lupus patients: Insights from the Spanish Society of Rheumatology Lupus Register (RELESSER) analysis of factors associated with heart failure
17. Effectiveness, safety and economic analysis of Benepali in clinical practice
18. Efectividad, seguridad y análisis económico de Benepali en práctica clínica
19. Contributions of the lupus register of the Spanish Society of Rheumatology (RELESSER) to the knowledge of systemic lupus erythematosus in Spain
20. Aportaciones del registro de lupus de la Sociedad Española de Reumatología (RELESSER) al conocimiento del lupus eritematoso sistémico en España
21. Analysis of clinical–analytical characteristics in patients with rheumatoid arthritis and interstitial lung disease: Case–control study
22. Análisis de las características clínico-analíticas de pacientes con artritis reumatoide y enfermedad pulmonar intersticial: casos y controles
23. Biological treatment patterns in patients with inflammatory joint diseases. Retrospective study with 4 years follow-up
24. Patrones de tratamiento biológico en pacientes con enfermedades articulares inflamatorias. Estudio retrospectivo de 4 años de seguimiento
25. Expert recommendations on the interleukin 6 blockade in patients with rheumatoid arthritis
26. Recomendaciones de experto sobre el bloqueo de la interleucina 6 en pacientes con artritis reumatoide
27. Efficacy and Safety of Rituximab in Vasculitic Neuropathy: A Systematic Review of the Literature
28. Eficacia y seguridad de rituximab en neuropatía vasculítica: revisión sistemática
29. Prevalence of Comorbidities in Rheumatoid Arthritis and Evaluation of Their Monitoring in Clinical Practice: The Spanish Cohort of the COMORA Study
30. Damage in a large systemic lupus erythematosus cohort from the Spanish Society of Rheumatology Lupus Registry (RELESSER) with emphasis on the cardiovascular system: a longitudinal analysis.
31. Analysis of Effectiveness, Safety and Optimization of Tocilizumab in a Cohort of Patients With Rheumatoid Arthritis in Clinical Practice
32. Análisis de la efectividad, seguridad y optimización de tocilizumab en una cohorte de pacientes con artritis reumatoide en práctica clínica
33. Integrative Clinical, Molecular, and Computational Analysis Identify Novel Biomarkers and Differential Profiles of Anti-TNF Response in Rheumatoid Arthritis
34. Déchiffrer la pneumopathie interstitielle diffuse associée à la polyarthrite rhumatoïde en utilisant une analyse en cluster hiérarchique non supervisée : résultats d’une collaboration internationale
35. Interpretable Inflammation Landscape of Circulating Immune cells
36. Incidence, associated factors and clinical impact of severe infections in a large, multicentric cohort of patients with systemic lupus erythematosus
37. Ixekizumab for the treatment of patients with active psoriatic arthritis and an inadequate response to tumour necrosis factor inhibitors: results from the 24-week randomised, double-blind, placebo-controlled period of the SPIRIT-P2 phase 3 trial
38. Recommendations by the Spanish Rheumatology Society for the Management of Patients Diagnosed With Rheumatoid Arthritis who Cannot Be Treated With Methotrexate
39. Documento de Recomendaciones de la Sociedad Española de Reumatología para el manejo clínico del paciente con artritis reumatoide que no puede utilizar metotrexato
40. LP-171 Fibromyalgia and glucocorticoids use drives self-perceived depression in systemic lupus erythematosus: insights from a large prospective and multicenter study using Relesserpros register’s database.
41. Quality Standards for Rheumatology Outpatient Clinic. The EXTRELLA Project
42. Estándares de calidad asistencial para las consultas externas de reumatología. El proyecto EXTRELLA
43. Eficiency of Different Doses of Rituximab in Rheumatoid Arthritis
44. Eficiencia de diferentes dosis de rituximab en la artritis reumatoide
45. POS1016 ANALYSIS OF GUT MICROBIOTA IN RHEUMATOID ARTHRITIS-ASSOCIATED INTERSTITIAL LUNG DISEASE
46. POS1056 CYTOKINE ANALYSIS IN PATIENTS WITH INTERSTITIAL LUNG DISEASE ASSOCIATED WITH RHEUMATOID ARTHRITIS
47. OP0229 CHANGES IN THE CAUSES AND PREDICTORS OF LUPUS MORTALITY IN SPAIN THROUGH THE LAST DECADES: DATA FROM THE RELESSER REGISTRY
48. OP0023 UNBIASED HIERARCHICAL CLUSTERING OF CIRCULATING MOLECULAR PROFILES IN RHEUMATOID ARTHRITIS PATIENTS DEFINES PRECISE CV RISK. EFFECTS OF TNFI, IL6RI, AND JAKINIBS
49. AB1677 VALIDATION ANALYSIS OF THE PHYSICIAN GLOBAL ASSESSMENT (PGA) SCALE IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS INCLUDED IN RELESSER-PROS REGISTRY
50. POS1041 LIPID METABOLISM IS DEEPLY ALTERED IN ACTIVE RHEUMATOID ARTHRITIS PATIENTS AND REVERSED BY ANTI-TNF, ANTI-IL6R, AND JAK-INHIBITORS
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.